Navigation Links
Caliper Life Sciences Launches Living Image(R) 4.0 Software
Date:12/3/2009

HOPKINTON, Mass., Dec. 3 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, today introduced Living Image 4.0 software for IVIS® in vivo imaging systems. Living Image software drives the more than 800 Caliper IVIS systems currently installed in laboratories worldwide. Living Image 4.0 features advanced spectral unmixing tools to enhance fluorescent sensitivity and automated 3D image acquisition and analysis providing an anatomical view of disease activity and drug efficacy.

Preclinical imaging for translational research is now routinely used in large scale studies for drug discovery and vaccine development. With Living Image 4.0, scientists can easily visualize and track diseases quantitatively, in small living animals through the sensitive detection of fluorescent and bioluminescent reporters and functional markers. 3D images generated with Living Image 4.0 can also be co-registered with CT or MRI results to provide enhanced anatomical context for optical molecular signals.

The software's new design creates an intuitive, seamless workflow for researchers of all skill levels. New features include: wizard based guidance for advanced imaging protocols, improved surface tomography, advanced spectral unmixing tools, new color templates and 3D visualization tools. All IVIS systems are calibrated to NIST standards to ensure that quantitative results are validated throughout an experiment and from location to location.

"Caliper's IVIS systems are widely recognized as the leading small animal molecular imaging instrument for drug discovery and development," said Kevin Hrusovsky, president and chief executive officer, Caliper Life Sciences. "Living Image 4.0 will further enhance IVIS's value to scientists
'/>"/>

SOURCE Caliper Life Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Caliper Life Sciences Expands Suite of Reagents Supporting the IVIS Family of In Vivo Imaging Systems
2. Caliper Life Sciences Launches IVIS(R) In Vivo Imaging System with X-Ray
3. Caliper Life Sciences Reports Second Quarter 2009 Results
4. Caliper Life Sciences Second Quarter 2009 Financial Results Conference Call Notice
5. Caliper Life Sciences Introduces Staccato Protein Workstation for Automated Protein Sample Preparation & Analysis
6. Caliper Life Sciences to Webcast Investor Session of Open House
7. Caliper Life Sciences Reports First Quarter 2009 Results
8. Caliper Life Sciences Announces Date and Location of its 2009 Annual Meeting of Stockholders
9. EPA Presents Initial Results from Caliper Life Sciences ToxCast Screening Effort
10. Caliper Life Sciences Reports Fourth Quarter and Full Year 2008 Results
11. Caliper Life Sciences Introduces Zephyr Genomics Workstation for Automated Liquid Handling
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , March 31, 2015  The Myeloma Crowd Research ... selection of ten proposals that will now be ... first patient-led, scientifically validated funding initiative uncovering solutions ... 2 of the MCRI included preliminary vetting by ... a large number of innovative projects focusing on ...
(Date:3/31/2015)... 2015 Diasome Pharmaceuticals, Inc. ( http://www.diasome.com ... that a United States patent has recently been allowed ... , Entitled “Lipid Construct for Delivery of Insulin ... claims related to the use of Diasome’s proprietary Hepatocyte ... insulin to more effectively reach the liver’s metabolic cells, ...
(Date:3/30/2015)... 2015  Heidrick & Struggles (Nasdaq: HSII ), the ... and culture shaping worldwide, today  announced that ... its global Healthcare and Life Sciences practice. As ... will lead a team of more than 80 partners, principals ... and Asia serving clients in the ...
(Date:3/30/2015)... OTTAWA , March 30, 2015 /CNW/ - A ... today on the salaries and demographic profiles of new ... "Opening the Door – Building Careers for New Grads ... Canada,s Research-Based Pharmaceutical Companies (Rx&D) and features ... federal Career Focus wage subsidy program from 2013 to ...
Breaking Biology Technology:Myeloma Crowd Research Initiative Selects 10 High-Risk Multiple Myeloma Proposals For Further Review 2Diasome Pharmaceuticals, Inc. Announces Notice of Allowance from US PTO for Liver Targeting System for Insulin 2Heidrick & Struggles Strengthens Leadership of Healthcare - Life Sciences Practice 2New Report on Graduates in Canadian Biotech Industry Sheds Light on Hiring Practices 2New Report on Graduates in Canadian Biotech Industry Sheds Light on Hiring Practices 3New Report on Graduates in Canadian Biotech Industry Sheds Light on Hiring Practices 4
... , Harness the Dual Benefits of Freshly Isolated Plateability and ... In today,s competitive environment and economic climate, the financial ... drug compound or chemical entity cannot be underestimated. Researchers and ... with less, and productivity and cost savings are at a ...
... SHENYANG, China, June 16 /PRNewswire-Asia-FirstCall/ ... ) ("A-Power" or "the Company"), a,leading provider of distributed ... of wind turbines, today announced it has signed a,contract ... systems using biomass as fuel in Henan Province of,China. ...
... SYDNEY, June 16 /PRNewswire-Asia/ -- Pharmaceutical company Pharmaxis,(ASX: PXS; Nasdaq: ... results of its,recently completed international Phase III trial of Bronchitol ... European Cystic Fibrosis,Conference in Brest, France. , ... 12 June by Dr Diana,Bilton of the Royal Brompton Hospital, ...
Cached Biology Technology:Celsis Outlines the Top Five Advantages of Cryo-plateable Hepatocytes 2Celsis Outlines the Top Five Advantages of Cryo-plateable Hepatocytes 3Celsis Outlines the Top Five Advantages of Cryo-plateable Hepatocytes 4A-Power Energy Generation Systems Ltd. Signs a Biomass-Based DG Contract with Sanmenxia New Energy Bio-Electricity Co., Ltd. 2A-Power Energy Generation Systems Ltd. Signs a Biomass-Based DG Contract with Sanmenxia New Energy Bio-Electricity Co., Ltd. 3Phase 3 Cystic Fibrosis Trial Results Presented at European Conference 2Phase 3 Cystic Fibrosis Trial Results Presented at European Conference 3Phase 3 Cystic Fibrosis Trial Results Presented at European Conference 4
(Date:3/23/2015)... , March 23, 2015  In the 2014 ... fraud case conviction losses. This figure accounts for a ... according to The Nilson Report, exceeds $11 billion globally. ... tool after a crime has occurred. Investor Mark ... polygraph expert Joe Paolella partnered to administer ...
(Date:3/20/2015)... Research and Markets ( http://www.researchandmarkets.com/research/4stcg3/india_sensors ... "India Sensors Market Forecast and Opportunities 2020" ... market is projected to grow at a CAGR ... automotive, industrial and healthcare sectors are the key ... addition, adoption of MEMS technology in sensors is ...
(Date:3/20/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces its biometric ... the products featured in 2015 "I Want That" International ... EST on the DIY Network.   DIY,s ... , site of the 2015 International CES for ...
Breaking Biology News(10 mins):Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 2India Sensors Market Forecast and Opportunities 2020 - STMicroelectronics held the largest share in 2014 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3
... production in algae, scientists at the U.S. Department of Energy,s ... metabolism by feeding them more carbon increases oil production as ... in the journal Plant and Cell Physiology on ... turn photosynthetic green algae into tiny "green factories" for producing ...
... Researchers have unveiled a novel strategy for neutralizing unwanted ... The strategy employs chains of binding agents, like "beads ... or more pathogenic molecules to neutralize their activity and ... low-cost, easy-to-replicate tool has demonstrated applications against several different ...
... Texas Children,s Hospital have identified commensal bacteria in ... may play a role in preventing or treating ... "We identified, to our knowledge, the first bifidobacterial ... large amounts of gamma-aminobutyric acid (GABA). This ...
Cached Biology News:Carbon is key for getting algae to pump out more oil 2Carbon is key for getting algae to pump out more oil 3Antitoxin strategy may help target other pathogens 2Antitoxin strategy may help target other pathogens 3Intestinal bacteria produce neurotransmitter, could play role in inflammation 2